Exploring the Efficacy of BMAC and ADSC Injections in Knee Osteoarthritis

Hosts: David Rosenblum,MD

Overview: In this episode, we delve into a recent study published in the Indian Journal of Orthopaedics that compares the therapeutic efficacy of Bone Marrow Aspirate Concentrate (BMAC) and Adipose-Derived Stem Cells (ADSCs) for treating knee osteoarthritis (OA). The study aims to provide insights into the effectiveness of these regenerative treatments and their correlation with mesenchymal stem cell (MSC) cellularity.

Key Points Discussed:

Background on Osteoarthritis:
- Definition and impact of OA, particularly in older populations.
- Overview of traditional treatments and the shift towards regenerative medicine.
Study Objectives:
- To compare the efficacy of BMAC and ADSC injections in symptomatic knee OA patients.
- To analyze MSC quantity and quality in harvested tissues from both sources.
Methodology:
- Description of the study design involving 60 patients with knee OA.
- Details on patient demographics, injection protocols, and follow-up assessments (VAS, WOMAC, ROM).
Results:
- Significant improvements in clinical scores for both BMAC and ADSC groups at 6 months.
- Discussion on the lack of significant correlation between MSC quantity and treatment efficacy.
- Insights into the success rates of MSC cultures from both bone marrow and adipose tissue.
Conclusions:
- Both treatments demonstrated clinical improvements, with no substantial differences between them.
- BMAC showed higher MSC counts and faster recovery rates, but further research is needed to understand the underlying factors affecting efficacy.
Implications for Clinical Practice:
- Considerations for clinicians when choosing between BMAC and ADSC treatments.
- Future directions for research in regenerative therapies for knee OA.

References:

Vitali, M., Ometti, M., Montalbano, F., et al. (2025). Bone Marrow Aspirate Concentrate (BMAC) Versus Adipose-Derived Stem Cells (ADSCs) Intra-articular Injection Therapeutic Efficacy in Knee OA Correlated to Their Mesenchymal Stem Cell (MSC) Cellularity: An Exploratory Comparative Pilot Study. Indian Journal of Orthopaedics. https://doi.org/10.1007/s43465-025-01525-z

Listener Engagement:

Join the conversation! Share your thoughts on BMAC and ADSC treatments for knee OA on social media using #JournalClubPodcast.
Don't forget to subscribe for more discussions on the latest research in orthopaedics and regenerative medicine.

BMAC vs Adipose Derived Stem Cell Injections in Knee Osteoarthritis